SchubartJR, GreenMJ, Van ScoyLJ, et al.: Advanced cancer and end-of-life preferences: Curative intent surgery versus noncurative intent treatment. J Palliat Med, 2015. [E-pub ahead of print.]
2.
BrahmerJ, ReckampKL, BaasP, et al.: Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med, 2015; 373:123–135.
3.
WeeksJC, CatalanoPJ, CroninA, et al.: Patients' expectations about effects of chemotherapy for advanced cancer. New Engl J Med, 2012; 367:1616–1625.
4.
GreenMJ, SchubartJR, WhiteheadMM, et al.: Advance care planning does not adversely affect hope or anxiety among patients with advanced cancer. J Pain Symptom Manage, 2014; 49:1088–1096.
